The Dompé of tomorrow

With a passion for innovation and a capacity for a long-term vision, Dompé farmaceutici has been on an incredible journey for 130 years. Our mission is to find new ways to strengthen and accelerate research to deliver more effective therapies.

"We have redefined our study areas as platforms based on the biological mechanisms to be investigated. For example, in the field of neuronal growth, we are working on neurotrophins, in immunology on diseases such as juvenile diabetes and we are active in pain, Covid and new approaches to drug discovery," explains Nathalie Dompé, Co-Ceo Dompé Pharmaceutical and Vice President of Business Development Dompé US.

Discovery, however, is not an individual achievement but a shared effort. In recent years, we have demonstrated our ability to anticipate change. As a result, we have exceeded our own goals: our biotech drug has become the first approved treatment for a rare ophthalmologic disease distributed globally.

For the next few years, with a view to constant evolution, our mission will be to strive to create the Dompé of tomorrow by continuing to transform the most challenging healthcare challenges into great opportunities.

Dompé farmaceutici S.p.A. Single shareholder company / Share capital € 50.000.000,00
REA MI 289519 - A registered company in Milan, Italy / Tax code and VAT number IT00791570153